STOCK TITAN

Glaukos (NYSE: GKOS) insider plans sale of 186,945 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Glaukos Corporation insider Thomas Burns has filed a notice of proposed stock sales under Rule 144. The filing covers 186,945 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $21,498,675.00 and 57,434,740 shares of common stock outstanding.

The shares to be sold were acquired on January 16, 2026 through the cash exercise of a stock option that was originally granted on March 10, 2016, with 186,945 shares acquired and paid in cash on that date. Over the prior three months, Burns sold 88,055 shares of Glaukos common stock on January 8, 2026 for gross proceeds of $10,126,325.00.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 filing discloses a sizable insider stock sale plan.

This notice shows Thomas Burns planning to sell 186,945 shares of Glaukos common stock under Rule 144 through Fidelity Brokerage Services LLC on the NYSE. The filing lists an aggregate market value of $21,498,675.00 for the proposed sale and indicates total common shares outstanding of 57,434,740.

The shares come from the cash exercise on January 16, 2026 of a stock option originally granted on March 10, 2016, with 186,945 shares acquired for cash. The filing also records that during the previous three months Burns sold 88,055 common shares on January 8, 2026 for gross proceeds of $10,126,325.00, providing additional context on recent selling activity.

Form 144 is a notice of intent rather than a guarantee that all shares will be sold, and actual sales can depend on market conditions and trading decisions. Future company filings and trade reports would reflect any completed transactions tied to this notice.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

Who is selling shares of Glaukos (GKOS) in this Form 144?

The notice identifies Thomas Burns as the person for whose account the Glaukos common stock is to be sold.

How many Glaukos (GKOS) shares are covered by this Rule 144 notice?

The filing covers 186,945 shares of Glaukos common stock, with an aggregate market value of $21,498,675.00 listed in the document.

How and when were the Glaukos (GKOS) shares to be sold acquired?

The 186,945 common shares were acquired on January 16, 2026 via an option originally granted on March 10, 2016, with the option exercised for cash on the same date.

What recent Glaukos (GKOS) stock sales has Thomas Burns made?

Over the past three months, the filing reports that Thomas Burns sold 88,055 Glaukos common shares on January 8, 2026 for gross proceeds of $10,126,325.00.

Which broker and exchange are involved in this Glaukos (GKOS) Form 144 sale?

The planned sale uses Fidelity Brokerage Services LLC as broker, with the common shares listed for sale on the NYSE.

How many Glaukos (GKOS) shares are outstanding according to this filing?

The document states that 57,434,740 shares of Glaukos common stock are outstanding.
Glaukos Corp

NYSE:GKOS

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

6.91B
55.54M
3.31%
107.34%
5.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO